SCHEMBL21709997

SCHEMBL21709997

Cc1ccc(OC(C)CCc2ccc(C#N)cc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.47
CYP2A6 P11509 2/20 0.47
ACACB O00763 2/20 0.43
CYP19A1 P11511 2/20 0.41
BCHE P06276 1/20 0.40
ACHE P22303 1/20 0.40
MMP12 P39900 1/20 0.39
MMP13 P45452 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
MAOB P27338 2/20 0.38
MAOA P21397 1/20 0.38
AR P10275 1/20 0.38
LMNA P02545 1/20 0.38
GAA P10253 1/20 0.38
HTT P42858 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
TSHR P16473 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8436335 0.76 MAPT (0.49) ALDH1A1MMP13MAOB
SCHEMBL9871755 0.76 GAA (0.43) ALDH1A1CYP2A6MAOBMAOAGAA
SCHEMBL11760865 0.75 HRH3 (0.40) ALDH1A1CYP2A6MAOBMAOAGAA
SCHEMBL13614190 0.75 ALDH1A1 (0.42) ALDH1A1CYP2A6MAOBGAA
SCHEMBL25801725 0.74 ACACB (0.47) ALDH1A1CYP2A6ACACBMAOBGAA
SCHEMBL25801724 0.74 ACACB (0.47) ALDH1A1CYP2A6ACACBMAOBGAA
SCHEMBL1445330 0.74 ACACB (0.47) ALDH1A1CYP2A6ACACBMAOBGAA
SCHEMBL7697419 0.74 ALDH1A1 (0.48) ALDH1A1CYP2A6MMP13HTTTSHR
SCHEMBL13617597 0.73 CYP2A6 (0.54) ALDH1A1CYP2A6CYP19A1MMP12MMP13
SCHEMBL10570749 0.73 CYP2A6 (0.67) ALDH1A1CYP2A6CYP19A1BCHEACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10981900-B2 Spiro compound and use thereof MEDSHINE DISCOVERY INC. (CN) 2021-04-20 US disclosed
US-20200048235-A1 SPIRO COMPOUND AND USE THEREOF MEDSHINE DISCOVERY INC. (CN) 2020-02-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200048235-A1 SPIRO COMPOUND AND USE THEREOF S1PR1, S1PR2, S1PR3 ALDH1A1 862/4885CYP2A6 1337/4885ACACB 2398/4885
US-10981900-B2 Spiro compound and use thereof S1PR1, S1PR2, S1PR3 ALDH1A1 862/4885CYP2A6 1337/4885ACACB 2398/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.